|
|
|
Volumn 25, Issue 9, 1998, Pages 1273-1277
|
|
Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BAX PROTEIN, HUMAN;
ONCOPROTEIN;
PROTEIN BAX;
PROTEIN BCL 2;
ADENOCARCINOMA;
ADENOSQUAMOUS CARCINOMA;
ARTICLE;
BIOSYNTHESIS;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
METABOLISM;
MIDDLE AGED;
MORTALITY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
RADIATION DOSE;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
ADENOCARCINOMA;
BCL-2-ASSOCIATED X PROTEIN;
CARCINOMA, ADENOSQUAMOUS;
CARCINOMA, SQUAMOUS CELL;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MIDDLE AGED;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RADIOTHERAPY DOSAGE;
SURVIVAL RATE;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0032110546
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
